2016
DOI: 10.1055/s-0042-117112
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Novel PROP1 and POU1F1 Mutations in Patients with Combined Pituitary Hormone Deficiency

Abstract: Growth hormone deficiency (GHD) results from variations affecting the production and release of growth hormone (GH) and is of 2 types: isolated growth hormone deficiency (IGHD) and combined pituitary hormone deficiency (CPHD). IGHD results from mutations in and while CPHD is associated with defects in transcription factor genes ,, and The present study reports on screening of, , and in CPHD patients and the novel variations identified. Fifty-one CPHD patients from 49 unrelated families clinically diagnosed on … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
27
0
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(29 citation statements)
references
References 27 publications
1
27
0
1
Order By: Relevance
“…However, with increasing knowledge about the etiology of hypopituitarism, nontumoral causes are becoming more evident [4]. In the recent years, new gene mutations affecting hypothalamo/pituitary embryogenesis have been revealed, and novel genetic causes of congenital hypopituitarism [5, 6] have been identified.…”
Section: Introductionmentioning
confidence: 99%
“…However, with increasing knowledge about the etiology of hypopituitarism, nontumoral causes are becoming more evident [4]. In the recent years, new gene mutations affecting hypothalamo/pituitary embryogenesis have been revealed, and novel genetic causes of congenital hypopituitarism [5, 6] have been identified.…”
Section: Introductionmentioning
confidence: 99%
“…Our previous study was conducted with a broad aim to ensure a widespread analysis of the genomic regions including the whole GH1 gene deletion, the GH1 promoter, and all 5 GH1 exons along with complete screening (13 exons) of the GHRHR gene in IGHD patients and all the coding exons of PROP1, POU1F1, and HESX1 in CPHD patients. The detailed findings on the molecular screening in IGHD and CPHD were reported separately [7,8]. In the present study, we build on our previous findings where several known and novel mutations were identified.…”
Section: Introductionmentioning
confidence: 67%
“…Participants were recruited as described previously [7,8]. Briefly, a total of 160 consecutive patients, diagnosed with IGHD or CPHD were recruited from the Pediatric and Adolescence Endocrine Clinic (PAEC); Department of Endocrinology & Metabolism, Pediatric Endocrine Clinic (PEC); Department of Pediatrics, AIIMS, New Delhi; and Department of Endocrinology and Metabolism, Army Hospital (Referral & Research, New Delhi).…”
Section: Participant's Recruitmentmentioning
confidence: 99%
See 2 more Smart Citations